glp 1 parkinson's disease Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Diseases | CNS Drugs How a 'blockbuster' treatment for
Description
Delivered a mean weight loss of up to 16.6 kg (36.6 lbs) in clinical trials
Principles of Diabetes Mellitus
Got questions about CONTRAVE
Statistics Make data-driven decisions to drive reader engagement, subscriptions, and campaigns
14,15 Another meta-analysis of 93 clinical trials showed that GLP-1 RAs increased the risk of early-stage DR compared with placebo, with this effect being driven by albiglutide in particular
